Canfeng Zhang

577 total citations
10 papers, 360 citations indexed

About

Canfeng Zhang is a scholar working on Molecular Biology, Cancer Research and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Canfeng Zhang has authored 10 papers receiving a total of 360 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 4 papers in Cancer Research and 2 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Canfeng Zhang's work include RNA modifications and cancer (5 papers), RNA Research and Splicing (4 papers) and Cancer-related molecular mechanisms research (3 papers). Canfeng Zhang is often cited by papers focused on RNA modifications and cancer (5 papers), RNA Research and Splicing (4 papers) and Cancer-related molecular mechanisms research (3 papers). Canfeng Zhang collaborates with scholars based in China, South Korea and Germany. Canfeng Zhang's co-authors include Yong Zhao, Haiying Liu, Liping Chen, Chen Xie, Haoxian Zhou, Wengong Wang, Yanru Zeng, Di Peng, Xiaotong Luo and Jian Ren and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nucleic Acids Research and The EMBO Journal.

In The Last Decade

Canfeng Zhang

9 papers receiving 358 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Canfeng Zhang China 6 320 117 34 31 26 10 360
Gertrud Kortman Netherlands 10 240 0.8× 157 1.3× 41 1.2× 28 0.9× 4 0.2× 17 307
Yuzhong Jeff Meng United States 2 210 0.7× 144 1.2× 18 0.5× 28 0.9× 2 0.1× 2 284
Penelope D. Ruiz United States 8 306 1.0× 28 0.2× 93 2.7× 101 3.3× 7 0.3× 10 404
Andrew M. Shafik United States 10 423 1.3× 220 1.9× 20 0.6× 13 0.4× 28 1.1× 15 466
Jen‐Hao Yang United States 11 357 1.1× 192 1.6× 11 0.3× 46 1.5× 4 0.2× 20 405
Xiaoyu Ma China 8 344 1.1× 149 1.3× 32 0.9× 19 0.6× 5 0.2× 18 418
Meixi Yu China 4 165 0.5× 81 0.7× 16 0.5× 7 0.2× 9 0.3× 4 201
Kinga Pajdzik United States 9 520 1.6× 209 1.8× 40 1.2× 42 1.4× 44 1.7× 15 584
Roberto Dinami Italy 7 251 0.8× 150 1.3× 31 0.9× 101 3.3× 3 0.1× 9 313
Qiuyue Yuan China 6 139 0.4× 83 0.7× 55 1.6× 13 0.4× 3 0.1× 9 231

Countries citing papers authored by Canfeng Zhang

Since Specialization
Citations

This map shows the geographic impact of Canfeng Zhang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Canfeng Zhang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Canfeng Zhang more than expected).

Fields of papers citing papers by Canfeng Zhang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Canfeng Zhang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Canfeng Zhang. The network helps show where Canfeng Zhang may publish in the future.

Co-authorship network of co-authors of Canfeng Zhang

This figure shows the co-authorship network connecting the top 25 collaborators of Canfeng Zhang. A scholar is included among the top collaborators of Canfeng Zhang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Canfeng Zhang. Canfeng Zhang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Guo, Siyao, Qiang Zhang, Jieyi Ma, et al.. (2025). PABPN1-C5 axis promotes hepatocellular carcinoma progression via NF-κB activation. Oncogene. 44(37). 3512–3524.
2.
Han, Hui, Wei Wei, Zixin Huang, et al.. (2024). RNA modification-related genes illuminate prognostic signature and mechanism in esophageal squamous cell carcinoma. iScience. 27(3). 109327–109327. 6 indexed citations
3.
Ma, Jieyi, Siyi Zheng, Chenrui An, et al.. (2024). Pathogenic mechanism and therapeutic intervention of impaired N 7 -methylguanosine (m 7 G) tRNA modification. Proceedings of the National Academy of Sciences. 121(45). e2405886121–e2405886121. 6 indexed citations
4.
Zhang, Canfeng, Liping Chen, Chen Xie, et al.. (2023). YTHDC1 delays cellular senescence and pulmonary fibrosis by activating ATR in an m6A-independent manner. The EMBO Journal. 43(1). 61–86. 23 indexed citations
5.
Zhang, Canfeng, Liping Chen, Kai Ren, et al.. (2023). BMAL1 collaborates with CLOCK to directly promote DNA double-strand break repair and tumor chemoresistance. Oncogene. 42(13). 967–979. 20 indexed citations
6.
Zhou, Haoxian, Chen Xie, Yanlian Chen, et al.. (2023). UBQLN1 deficiency mediates telomere shortening and IPF through interacting with RPA1. PLoS Genetics. 19(7). e1010856–e1010856. 3 indexed citations
7.
Peng, Qianqian, Yu Liu, Canfeng Zhang, et al.. (2022). Genetic Variants in Telomerase Reverse Transcriptase Contribute to Solar Lentigines. Journal of Investigative Dermatology. 143(6). 1062–1072.e25. 3 indexed citations
8.
Chen, Liping, Canfeng Zhang, Wenbin Ma, et al.. (2022). METTL3-mediated m6A modification stabilizes TERRA and maintains telomere stability. Nucleic Acids Research. 50(20). 11619–11634. 71 indexed citations
9.
Zhang, Canfeng, Liping Chen, Di Peng, et al.. (2020). METTL3 and N6-Methyladenosine Promote Homologous Recombination-Mediated Repair of DSBs by Modulating DNA-RNA Hybrid Accumulation. Molecular Cell. 79(3). 425–442.e7. 227 indexed citations
10.
Yang, Feiya, et al.. (2017). Metanephric Adenofibroma in a young adult. International braz j urol. 43(3). 563–565. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026